Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Deloitte
Mallinckrodt
Argus Health
Teva
UBS
Federal Trade Commission
Merck
Queensland Health

Generated: January 16, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,188,146

« Back to Dashboard

Which drugs does patent 8,188,146 protect, and when does it expire?

Patent 8,188,146 protects VASCEPA and is included in one NDA.

This patent has forty-one patent family members in thirty-four countries.

Summary for Patent: 8,188,146
Title:Highly purified ethyl EPA and other EPA derivatives
Abstract: A pharmaceutical preparation comprising EPA in an appropriately assimilable form where of all the fatty acids present in the preparation at least 90%, and preferably at least 95%, is in the form of EPA and where less than 5%, and preferably less than 3%, is in the form of DHA is provided.
Inventor(s): Peet; Malcolm (Sheffield, GB), Vaddadi; Krishna S. (Melbourne, AU)
Assignee: Amarin Corporation Plc. (Dublin, IE)
Application Number:12/052,598
Patent Claim Types:
see list of patent claims
Composition; Dosage form;

Drugs Protected by US Patent 8,188,146

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-001 Jul 26, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-002 Feb 16, 2017 RX Yes No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,188,146

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9901809.5Jan 27, 1999

International Family Members for US Patent 8,188,146

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 300296 ➤ Sign Up
Australia 3065700 ➤ Sign Up
Brazil 0007743 ➤ Sign Up
Canada 2360776 ➤ Sign Up
China 100423718 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Chubb
Accenture
Mallinckrodt
McKesson
US Department of Justice
Fish and Richardson
UBS
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.